Fortune Brands Innovations, Inc. (FBIN) Form 10-Q — Aug 5, 2026
Fortune Brands Innovations reported a second-quarter net loss of $22.5 million, or $0.19 per diluted share, versus net income of $100.3 million, or $0.83 per share, a year earlier, as six-month net sales fell 3.2% to $2,165.2 million on soft volumes across all three segments. The swing to a loss was driven primarily by $228.7 million of impairment charges on the Fiberon composite decking business, which management placed under formal strategic review on May 27, 2026; the Outdoors segment posted a $160.0 million six-month operating loss, and the company cautioned that changes in assumptions or outcomes of the review could produce additional impairment charges.
Key figures
- Eps
- 0.01 diluted (26 weeks); -0.19 diluted (Q2)
- Net Income
- 1.7M (26 weeks); -22.5M (Q2)
- Revenue Yoy
- -3.2% (twenty-six weeks)
- Total Assets
- 6342
- Cash Position
- 209.7
- Buybacks 26wk
- 1.0 million shares for $45.2 million
- Dividend declared
- $0.26/share payable September 9, 2026
- Dividends paid 26wk
- 62.2
- Senior notes principal
- 2.2 billion
- Q2 prior year net sales
- 1203.3
- Tariff refunds received
- 8.9
- Fiberon impairment total
- 228.7
- Operating cash flow 26wk
- 83.6
- Q2 prior year net income
- 100.3
- Tariff refund receivable
- 122.1
- Revolving credit facility
- 1.25 billion (undrawn)
- Commercial paper outstanding
- 374.2
- Fiberon tradename impairment
- 7.5
- Tariff refund cogs reduction
- 104.2
- Asset impairment charges 26wk
- 229.3
- Remaining buyback authorization
- 782.1
- Shares outstanding july 17 2026
- 119371477
- Fiberon long lived asset impairment
- 221.2
- Prior year operating cash flow 26wk
- 66
- Governance and leadership change costs
- 43.6
Price after filing
Close on the filing date to close N calendar days later (from $52.17). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.